HLA-G was aberrantly enriched in a variety of tumors (Fig. 2), including colorectal cancer [88], gastric cancer [89], ovarian cancer [90–93], thyroid cancer [40], cervical cancer [78, 94], and endometrial cancer [95–97]. Here, HLA-G is linked to endometrial cancer.